{
  "id": 11231,
  "url": "https://siliconangle.com/2026/07/14/chai-discovery-nabs-400m-series-c-ai-designed-antibodies-reach-big-pharma",
  "title": "Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma",
  "summary": "Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in new funding, nearly tripling its valuation to $3.8 billion. Index Ventures led the Series C round alongside Kleiner Perkins, Sequoia Capital and Dimension. New investors joining the investment included Bain Capital […] The post Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma appeared first on",
  "authors": "Kyt Dotson",
  "category": "news",
  "topics": "finance-investment,biotech",
  "orgs": null,
  "regions": null,
  "published_at": "2026-07-14T15:40:31.000Z",
  "fetched_at": "2026-07-17T05:10:53.887Z",
  "source_slug": "x-siliconangle-ai",
  "source_name": "SiliconANGLE AI",
  "source_homepage": "https://siliconangle.com/category/ai/",
  "ethics_ai_record_url": "https://ethics.ai/record/11231",
  "original_url": "https://siliconangle.com/2026/07/14/chai-discovery-nabs-400m-series-c-ai-designed-antibodies-reach-big-pharma",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}